期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

治疗支气管哮喘的新的药物进展

Treatment bronchial tube asthma the new medicine to progress
原文传递
导出
摘要 本文对治疗哮喘研究和开发阶段的：抗IgE治疗、磷酸二酯酶-4（PDE-4）抑制剂、抗白介素-4（IL-4）抗体和抗白介素-5（IL-5）抗体、卡介苗（BCG）和微卡、基因治疗的作用机制、临床应用和不良反应做一综述. This article to treats asthma research and the phase of exploitation：The anti-IgE treatment, the phosphoric acid diesterase - 4（PDE-4.） inhibitor,anti-Bai Jiesu the - 4（IL-4） immune body and anti-Bai Jiesu the - 5（IL-5） immune body, BCG vaccine （BCG） and the microcalorie, the gene treatment function machine-made, the clinical practice and responded not good makes a summary.
作者 郭红喜 刘华
机构地区 广东药学院附属第一医院
出处 《按摩与康复医学》 2011年第3期69-69,共1页 Chinese Manipulation and Rehabilitation Medicine
关键词 支气管哮喘 药物治疗 Bronchial tube asthma Medicine treatment
分类号 R4 [医药卫生—临床医学]
  • 相关文献

参考文献6

  • 1中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2008).
  • 2Dirkje S.Postma & Huib A.M.Kerstjens &Nick H.T.ten Hacken,Inhaled corticosteroids and long-acting beta-agonists in adult asthma:a winning combination in all? Naunyn-Schmiedeberg's Arch Pharmacol (2008) 378:203–215.
  • 3Por L.Campusano a,M.Pastenes a,C.Fontecilla a,J.Escalona a,C.Salazar a,J.A.Castro-Rodriguez b,Response to budesonide among atopic and non-atopic infants/preschoolers with recurrent wheezing llergolImmunopathol (Madr).2010;38:31-6.
  • 4陈欣,林江涛.支气管哮喘的药物治疗[J].临床药物治疗杂志,2008,6(1):18-22. 被引量：3
  • 5Astrid M Doerner1 and Bruce L Zuraw*1,2,TGF-β1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1 but not abrogated by corticosteroids Respiratory Research2009,0:100.
  • 6Kyuma Ota1,Takashi Hasegawa2,Analysis of Inhaled Corticosteroid Selection in Patients with Bronchial Asthma Using a Questionnaire Survey―Effects of Age,Gender,and Disease Severity―Allergology International.2009;58:365-371.

二级参考文献11

  • 1[1]Global Strategy for Asthma Management and Prevention,NIH,upated 2005
  • 2[3]Weinberger M,Hendeles L.Theophylline in asthma.N Engl J Med,1996,334:1380-1388
  • 3[4]Boulet LP.Long-versus short-acting beta 2-agonists.Implications for drug therapy.Drugs,1994,47:207-222
  • 4[5]Wallin A,Sandstrom T,Soderberg M,et al.The effects of regular inhaled formoterol,budesonide,and placebo on mucosal inflammation and clinical indices in mild asthma.Am J Respir Crit Care Med,1999,159:79-86
  • 5[6]Pauwels RA,Pedersen S,Busse WW,et al.for the START GerInvestigators Group.Early intervention with budesonide in mild persistent asthma:a randomized,double-blind trial.Am J Respir Crit Care Med,2003,361 (9363):1066-1067
  • 6[7]O'Byrne PM,Barnes PJ,Rodriguez-Roisin R,et al.Low dose inhaled budesonide and formoterol in mild persistent asthma:the OPTIMA randomized trial,2001,164 (8):1392-1397
  • 7[8]Spritzer WO,Suissa S,Ernst P,et al.The use of beta-agonists and the risk of death and near death from asthma.N Engl J Med,1992,326:501-506
  • 8[9]Lofdahl CG,Reiss TF,Leff JA,et al.Randomised,placebo controlled trial of effect of a leukotriene receptor antagonist,montelukast,on tapering inhaled corticosteroids in asthmatic patients.BMJ,1999,319:87-90
  • 9[10]Salmun LM,Barlan I,Wolf HM,et al.Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma:a double-blind,placebocontrolled,randomized trial.J Allergy Clin Immunol,1999,103:810-815
  • 10[11]Rafferty P,Jackson L,Smith R,a potent histamine H1-receptor antagonist in the treatment of grass pollen sensitive asthma.Br J Clin Pharmacol,1990,30:229-235

共引文献6

按摩与康复医学
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部